Projects per year
Personal profile
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Projects
- 30 Finished
-
GCatheter for Large Volume Intraparenchymal Brain Therapies
Pluhar, L. (PI)
CREOSALUS INC., NATIONAL INSTITUTES OF HEALTH (NIH)
9/1/22 → 8/31/23
Project: Research project
-
Investigation of mechanisms of resistance to immunotherapy in dogs with spontaneous high-grade glioma
Arnold, S. A. (PI), Olin, M. R. (CoI) & Pluhar, L. (CoI)
3/1/21 → 8/31/22
Project: Research project
-
Elucidating the immunosuppressive mechanism(s) of tumor vascular endothelial cells to develop immunotherapy for CNS tumors
Pluhar, L. (PI), Arnold, S. A. (CoI) & Olin, M. R. (CoI)
V FOUNDATION FOR CANCER RESEARCH
1/15/21 → 1/15/25
Project: Research project
-
Novel combined immunotherapeutic strategies for glioma: using pet dogs as a large animal spontaneous model
Pluhar, L. (PI), Arnold, S. A. (CoI), O'Sullivan, G. (CoI) & Olin, M. R. (CoI)
9/1/20 → 8/31/23
Project: Research project
-
Breed-Associated Differences in Differential Gene Expression Following Immunotherapy-Based Treatment of Canine High-Grade Glioma
Arnold, S. A., Low, W. C. & Pluhar, G. E., Jan 2025, In: Animals. 15, 1, 28.Research output: Contribution to journal › Article › peer-review
Open Access -
Immunotherapy yields breed-specific worst survival outcomes among three investigated therapies in French bulldogs with high-grade glioma
Arnold, S. A., Taylor, A. R., Hansen, K., Agarwal, V., Low, W. C. & Pluhar, G. E., 2025, In: Frontiers in Veterinary Science. 12, 1532439.Research output: Contribution to journal › Article › peer-review
Open Access -
Comparison of peripheral leukocyte parameters in patients receiving conventionally and hypofractionated radiotherapy schemes for the treatment of newly diagnosed glioblastoma
Greenlund, L., Shanley, R., Mulford, K., Neil, E. C., Lawrence, J., Arnold, S., Olin, M., Pluhar, G. E., Venteicher, A. S., Chen, C. C., Ferreira, C., Reynolds, M., Cho, L. C., Wilke, C., Shoo, B. A., Yuan, J., Dusenbery, K., Kleinberg, L. R., Terezakis, S. A. & Sloan, L., 2023, In: Frontiers in immunology. 14, 1284118.Research output: Contribution to journal › Article › peer-review
Open Access -
Establishment and characterization of two novel patient-derived lines from canine high-grade glioma
Schrock, M. S., Zalenski, A. A., Tallman, M. M., Kollin, L., Bratasz, A., Weeks, G., Miller, M. A., Sweeney, C. N., Pluhar, G. E., Olin, M. R., Kisseberth, W. C., Bentley, R. T., Dickinson, P. J., York, D., Webb, A., Wang, X., Moore, S., Venere, M. & Summers, M. K., Sep 2023, In: Veterinary and Comparative Oncology. 21, 3, p. 492-502 11 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
CD200AR-L: mechanism of action and preclinical and clinical insights for treating high-grade brain tumors
Moertel, C., Martinez-Puerta, F., Pluhar, G. G. E., Castro, M. G. & Olin, M., 2022, In: Expert Opinion on Investigational Drugs. 31, 9, p. 875-879 5 p.Research output: Contribution to journal › Editorial › peer-review
Open Access6 Scopus citations